View in EDS HTML Full Text PDF Full Text

Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer's disease.

Saved in:
Bibliographic Details
Title: Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer's disease.
Authors: Budda, Balasubrahmanyam1 (AUTHOR) balasubrahmanya.budda@alector.com, Mitra, Ananya1 (AUTHOR), Park, Lovingly1 (AUTHOR), Long, Hua1 (AUTHOR), Kurnellas, Michael2 (AUTHOR), Bien-Ly, Nga1 (AUTHOR), Estacio, William3 (AUTHOR), Burgess, Brady1 (AUTHOR), Chao, Grace1 (AUTHOR), Schwabe, Tina4 (AUTHOR), Paul, Robert4 (AUTHOR), Kenkare-Mitra, Sara1 (AUTHOR), Rosenthal, Arnon1 (AUTHOR)
Source: Alzheimer's Research & Therapy. 7/25/2025, Vol. 17 Issue 1, p1-21. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17589193
DOI:10.1186/s13195-025-01817-4